|
|
|
|
|
|
by _Gyan_
1910 days ago
|
|
|
The primary endpoint is symptomatic infection, not any infection per se. And it's a bit of a kludge, as all the Phase III protocols I've read define symptomatic infection as X no. of symptoms for Y+ no. of days i.e. there are people with fewer symptoms who aren't counted (or even tested to check for infection). The efficacy is the 1-relative risk of the primary endpoint. |
|
|